Lexicon Pharmaceuticals Receives Formal Dispute Resolution Request Decision From FDA’s Office of New Drugs for Sotagliflozin in Type 1 Diabetes

by NASDAQ Market News December 2, 2019

NASDAQ Market News
Click here to email author

Aptose to Present at 31st Annual Piper Jaffray Healthcare Conference

European Medicines Agency Accepts for Review Marketing Authorization Application for Amarin’s Icosapent Ethyl (Vascepa®) for Reduction of Cardiovascular Risk in High-Risk Patients, as Reflected in REDUCE-IT® Study

Ads